Life Science Cares (LSC) Boston proudly announces the election of three distinguished individuals to its esteemed Board of Managers: Jeb Keiper, M.S., MBA, CEO of Nimbus Therapeutics; Jodie Morrison, CEO of Q32 Bio; and Deborah Palestrant, Ph.D., MBA, Partner and Executive Chair of 4:59 Initiative at 5AM Ventures.

“The Life Science Cares Boston board plays a pivotal role in charting the course for the organization’s philanthropic initiatives, leveraging the resources and influence of the life science industry to uplift local communities. By electing new leaders like Jeb, Jodie, Deborah we are enriching the breadth of expertise within the board, enabling the organization to tap into a wider range of perspectives and propelling innovative solutions forward. With the collective guidance of these new board members, we are confident that Life Science Cares will continue to drive transformative change in the greater Boston community,” said Abe Ceesay, CEO of Rapport Therapeutics and Chair of the LSC Boston Board of Managers.

About the New LSC Boston Board Members:

Jeb Keiper, M.S., MBA, brings a wealth of experience as CEO of Nimbus Therapeutics, where he has spearheaded the progression of multiple programs into clinical testing, secured substantial funding, and facilitated transformative deals. With a background encompassing leadership roles at GSK and McKinsey, Jeb holds degrees from the Massachusetts Institute of Technology and an M.B.A. from the MIT Sloan School of Management with a joint program in Biomedical Enterprises with the Harvard Medical School.

“Greater Boston has the highest density of life sciences companies in the world, and as an industry dedicated to the advancement of human health and the alleviation of suffering, it is incumbent upon our sector to care not just for patients across the world, but for the neighbor next to us. Life Science Cares has galvanized our sector into philanthropic service with local organizations that improve the lives of those living in poverty and need right here in Greater Boston. Serving alongside so many other industry leaders to increase the positive impact of Life Science Cares is an honor,” said Mr. Keiper.

Jodie Morrison, a seasoned leader in the life sciences sector, is CEO of Q32 Bio and founder of the CEO Forum. Her previous roles include venture partner at Atlas Venture and multiple executive roles at Cadent, Keryx, Syntimmune and Tokai. Her track record of success includes orchestrating strategic mergers, acquisitions, and public offerings, as well as founding the CEO Forum, which brings CEOs across the industry together to support one another through challenges beginning with the COVID-19 pandemic. Ms. Morrison received her business training through the GBEP program at the MIT Sloan School of Management, her clinical research certification from Boston University School of Medicine and her B.A. in neuroscience from Mount Holyoke College. Recognized many times for her contributions to the life sciences industry, her accolades include the Boston Business Journal’s “Power 50” and “Women to Watch” awards.

“With a mission to address poverty and inequity, Life Science Cares has inspired life science companies and our employees to work together to serve a greater good in communities where we are building our companies,” Ms. Morrison said. “I am honored to join the board and be a part of expanding these important objectives here in the Greater Boston area and beyond.”

Deborah Palestrant, Ph.D., MBA, brings over 20 years of industry expertise to the LSC Boston board and is a Partner and Executive Chair of 4:59 Initiative at 5AM Ventures. She is a member of the board of directors of Latigo Biotherapeutics and Nido Biosciences. Before 5AM Ventures, she held business and corporate development roles at Relay Therapeutics and Editas Medicine and was part of the founding teams that helped build Blueprint Medicines and Editas Medicine while she was a senior associate at Third Rock Ventures. She holds a Ph.D. in biochemistry and molecular biophysics from Columbia University and an MBA from Northeastern University, and she was a Damon Runyon Cancer Research Foundation Postdoctoral Fellow at The Scripps Research Institute. Dr. Palestrant’s scientific background and business acumen make her a valuable addition to the board.

“I’m inspired by how Life Science Cares has mobilized the greater Boston biotech ecosystem to give back to the communities where we live and work,” said Dr. Palestrant. “Joining this board is a privilege. Our shared mission is to enhance the lives of people, and I look forward to working with my peers to expand these efforts and make a meaningful impact in the community.”

The LSC Boston Board of Managers is crucial in shaping the organization’s strategic direction and ensuring financial stability. By expanding its board with leaders of such caliber, LSC is poised to further its mission of addressing poverty and inequality in Greater Boston. For more information about Life Science Cares, please visit

About Life Science Cares:

Life Science Cares leverages the resources of the life sciences industry to collaborate with nonprofits and tackle societal challenges. With a focus on basic needs, education, and opportunity, LSC operates in five key hubs across the United States, fostering impactful partnerships with local organizations. Learn more at